' Tentative ' FDA Nod to Trokendi XR for Migraine Prevention ' Tentative ' FDA Nod to Trokendi XR for Migraine Prevention

The agency granted tentative approval to expand the label for an extended-release topiramate product, already approved for epilepsy, to include prophylaxis of migraine in adults, pending expiry of pediatric exclusivity in 2017.FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news